When researchers fed mosquitoes a drug used to treat people for obesity, the insects were less interested in hunting for their next human meal ticket. Karen Hopkin reports.
Scientists are working to correct a genetic defect in cystic fibrosis patients by having them inhale RNA. Christopher Intagliata reports.
The gene targeted for its role in HIV is linked to increased severity of other infectious diseases—and has implications for learning in mice
Experts say the risks of a controversial procedure outweigh the benefits for twin newborns
Gene editing and stem cell research have allowed for alternative rodent reproduction
Draft guidelines permit gene-editing tools for research into early human development, but would discourage manipulation of embryos for reproduction
James P. Allison and Tasuku Honjo share the Nobel Prize for their work on harnessing the cancer patient's own immune system to destroy tumors.
Researchers at the Mount Sinai Diabetes Center have already developed an artificial pancreas. Next, a drug that could regenerate pancreatic cells in the body.
Immunologist James Allison has spent over thirty years studying T cells and developing strategies for cancer immunotherapy. Now, he’s looking at new ways to unleash the immune system to eradicate cancer...
Interview: Joan Argetsinger Steitz weighs in on #MeToo and working with James Watson
New device gives an amputee the ability to feel the location of his foot
As Ebola outbreaks occur again and again, the scramble for answers and medications is ongoing
Shutting down an overactive enzyme could become a general treatment, rather than one solely intended for the few who inherit a mutated Parkinson’s gene
A flurry of recent findings highlight a contentious question in this area
A next-generation cochlear implant might allow the hearing-impaired to listen to music and cope with noise
Activating the reward system boosts anti-tumor immunity in mice
The controversy over how many genes are contained in the human genome continues to simmer
The preliminary findings raise questions about one of the ways this tech edits genomes
Three patients in Japan will receive the experimental therapy in the next year
The swallowable device looks promising in pigs